Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29443521 | 0.85 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL25336931 | 0.85 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL25339454 | 0.82 | HSP90AA1 (0.40) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL29443557 | 0.82 | HSP90AA1 (0.32) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL29443533 | 0.82 | HSP90AA1 (0.40) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL25337912 | 0.82 | HSP90AA1 (0.32) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL29443523 | 0.78 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL25338750 | 0.78 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL25339159 | 0.78 | CYP1A2 (0.37) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL25339865 | 0.78 | CYP1A2 (0.32) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240032541-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2024-02-01 | — | — | US | disclosed |
| EP-4210489-A1 | HERBICIDAL COMPOUNDS | Syngenta Crop Protection AG (CH) | 2023-07-19 | — | — | EP | disclosed |
| WO-2022053422-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2022-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240032541-A1 | HERBICIDAL COMPOUNDS | HAX1, DDT, MTX1 | CYP1A2 76/4885CYP3A4 1642/4885CYP2D6 263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.